What's Happening?
In 2025, the Royal Pharmaceutical Society (RPS) published 377 articles across its four research journals, marking a 25% increase from the previous year. These publications, in partnership with Oxford University Press, covered a wide range of topics including
new drug developments for cancer and kidney disease, pharmacists' independent prescribing, and efforts to combat antimicrobial resistance. The journals also addressed the environmental impact of medicines and transparency in pharmaceutical health systems. The International Journal of Pharmacy Practice (IJPP) featured a special collection on sustainable medicine use, while the Journal of Pharmaceutical Health Services Research (JPHSR) focused on transparency and accountability in pharmaceutical services. The Journal of Pharmacy and Pharmacology (JPP) celebrated its 25th anniversary under the editorial leadership of David Jones, and RPS Pharmacy & Pharmacology Reports (RPSPPR) welcomed new editorial leadership.
Why It's Important?
The increase in published research by the RPS highlights the growing emphasis on advancing pharmaceutical sciences and improving patient care. The focus on sustainable medicine use and transparency in pharmaceutical services reflects a broader industry trend towards environmental responsibility and ethical governance. These developments are crucial as they address global challenges such as climate change and corruption in healthcare systems. The research also supports the RPS's mission to place pharmacy at the forefront of patient care, potentially influencing policy and practice in the pharmaceutical industry. This could lead to more sustainable practices and improved healthcare outcomes, benefiting both the environment and public health.
What's Next?
In 2026, the RPS journals plan to continue addressing topical issues through themed collections, with IJPP and JPHSR currently seeking submissions on relevant topics. This ongoing research and publication effort will likely continue to shape the future of pharmacy practice and policy. The focus on sustainability and transparency may prompt further industry-wide changes, encouraging other organizations to adopt similar practices. The RPS's commitment to advancing pharmaceutical sciences suggests that the organization will remain a key player in driving innovation and ethical standards in the field.
